Celgene (CELG) Tops Q4 EPS by 2c, Offers FY17 Guidance
Tweet
Share
E-mail
Get Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Total costs and expenses: 2.57B
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total costs and expenses: 2.57B
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Celgene (NASDAQ: CELG) reported Q4 EPS of $1.61, $0.02 better than the analyst estimate of $1.59. Revenue for the quarter came in at $2.98 billion versus the consensus estimate of $3.02 billion.
GUIDANCE:
Celgene sees FY2017 EPS of $7.10-$7.25, versus the consensus of $7.13. Celgene sees FY2017 revenue of $13-13.4 billion, versus the consensus of $13.3 billion.
For earnings history and earnings-related data on Celgene (CELG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
